Metraipolis › archive › dc_a44d38d7cf32

SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob — Europe PMC PMID:41828692

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41828692
DOI
10.3390/ijms27052466
License (as archived)
solo-consultazione
Archived
2026-11-05T00:38:46.910Z
SHA-256 of the archived text
6fb97f8921b9b88d99c16c41550e5b22e4447b927334f78febd54c8f05d9f647
Stable URL of this page
https://metraipolis.com/documento/dc_a44d38d7cf32

How to cite

SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob — Europe PMC PMID:41828692 — Europe PMC (en), https://europepmc.org/article/MED/41828692 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a44d38d7cf32 (Metraipolis archive dc_a44d38d7cf32, sha256 6fb97f8921b9b88d99c16c41550e5b22e4447b927334f78febd54c8f05d9f647)
BibTeX
@misc{dca44d38d7cf32,
  title = {SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob — Europe PMC PMID:41828692},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41828692},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a44d38d7cf32; sha256 6fb97f8921b9b88d99c16c41550e5b22e4447b927334f78febd54c8f05d9f647},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41828692. Agents can read the archived copy with the MCP tool read_document.